Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
251 USD | +0.94% | +3.30% | +31.15% |
03/07 | Jerome Powell did it again | |
03/07 | JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.15% | 3.15TCr | |
+18.97% | 4.44TCr | |
+41.98% | 4TCr | |
-10.06% | 3.77TCr | |
-7.79% | 2.73TCr | |
+13.32% | 2.63TCr | |
+43.05% | 1.38TCr | |
+31.28% | 1.25TCr | |
-7.41% | 1.13TCr | |
-15.54% | 1.04TCr |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160